Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
Background. Hydroxychloroquine with or without azithromycin was one of the common therapies at the beginning of the COVID-19 pandemic. They can prolong QT interval, cause torsade de pointes, and lead to sudden cardiac death. We aimed to assess QT interval prolongation and its risk factors in patient...
Main Authors: | Seyed Parsa Eftekhar, Sohrab Kazemi, Mohammad Barary, Mostafa Javanian, Soheil Ebrahimpour, Naghmeh Ziaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/6683098 |
Similar Items
-
Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
by: B K Anupama MBBS, et al.
Published: (2020-08-01) -
Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
by: Gökhan Aksel, et al.
Published: (2020-01-01) -
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
by: Vincenzo Russo, et al.
Published: (2020-10-01) -
Correlation between seizure in children and prolonged QT interval
by: Saeid Sadrnia, et al.
Published: (2013-01-01) -
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
by: Kazimieras Maneikis, et al.
Published: (2021-02-01)